Extent of Peritoneal Metastases from Colorectal Cancer is Not Associated with Changes in Thrombin Generation or Fibrinolysis

Overview

Journal Pleura Peritoneum

Date 2024 Dec 23

PMID 39712293

Authors

Mikkel Lundbech

Andreas Engel Krag

Lene Hjerrild Iversen

Birgitte Brandsborg

Anne-Mette Hvas

Affiliations

Soon will be listed here.

Abstract

Objectives: Cancer cells can activate coagulation and inhibit fibrinolysis. The aim was to investigate the association between the burden of peritoneal metastases from colorectal cancer (PM-CRC) and biomarkers reflecting thrombin generation and fibrinolysis.

Methods: A cohort of 55 patients with PM-CRC scheduled for cytoreductive surgery. Patients were grouped by the peritoneal cancer index (PCI) assessed intraoperatively into limited PM-CRC (PCI≤15) and extensive PM-CRC (PCI>15). Blood samples were obtained before surgery. Thrombin generation was measured by thrombin-antithrombin complex (TAT) and prothrombin fragment 1+2 (F1+2), and ex vivo by the endogenous thrombin potential (ETP). Fibrinolysis was analyzed with fibrin clot lysis assay, fibrinogen, and D-dimer.

Results: Non-significantly decreased thrombin generation by F1+2 (p=0.72), TAT (p=0.32), and ETP (p=0.19) were observed in patients with extensive PM-CRC (n=9) compared with limited PM-CRC (n=46). Non-significantly prolonged 50 % clot lysis time were found in patients with extensive PM-CRC than in patients with limited PM-CRC.

Conclusions: Minor non-significant differences in thrombin generation and fibrinolysis were found between patients with extensive PM-CRC and limited PM-CRC. Thus, increased peritoneal metastatic burden from colorectal cancer does not seem to affect thrombin generation and fibrinolysis.

References

Verheij F, Bakkers C, van Eden W, Aalbers A, Nienhuijs S, Jozwiak K . Comparison of the Peritoneal Cancer Index and Dutch region count as tools to stage patients with peritoneal metastases of colorectal cancer. BJS Open. 2020; . PMC: 7709381. DOI: 10.1002/bjs5.50313. View

Oya M, Akiyama Y, Okuyama T, Ishikawa H . High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer. Jpn J Clin Oncol. 2001; 31(8):388-94. DOI: 10.1093/jjco/hye075. View

Mulder F, Horvath-Puho E, van Es N, van Laarhoven H, Pedersen L, Moik F . Venous thromboembolism in cancer patients: a population-based cohort study. Blood. 2020; 137(14):1959-1969. DOI: 10.1182/blood.2020007338. View

Bakkers C, Lurvink R, Rijken A, Nienhuijs S, Kok N, Creemers G . Treatment Strategies and Prognosis of Patients With Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study. Ann Surg Oncol. 2021; 28(13):9073-9083. PMC: 8591028. DOI: 10.1245/s10434-021-10190-z. View

Lundbech M, Krag A, Christensen T, Hvas A . Thrombin generation, thrombin-antithrombin complex, and prothrombin fragment F1+2 as biomarkers for hypercoagulability in cancer patients. Thromb Res. 2020; 186:80-85. DOI: 10.1016/j.thromres.2019.12.018. View

Stender M, Frokjaer J, Larsen T, Lundbye-Christensen S, Thorlacius-Ussing O . Preoperative plasma D-dimer is a predictor of postoperative deep venous thrombosis in colorectal cancer patients: a clinical, prospective cohort study with one-year follow-up. Dis Colon Rectum. 2009; 52(3):446-51. DOI: 10.1007/DCR.0b013e318197e2b2. View

Cervantes A, Adam R, Rosello S, Arnold D, Normanno N, Taieb J . Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022; 34(1):10-32. DOI: 10.1016/j.annonc.2022.10.003. View

Razak N, Jones G, Bhandari M, Berndt M, Metharom P . Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment. Cancers (Basel). 2018; 10(10). PMC: 6209883. DOI: 10.3390/cancers10100380. View

Shigemori C, Wada H, Matsumoto K, Shiku H, Nakamura S, Suzuki H . Tissue factor expression and metastatic potential of colorectal cancer. Thromb Haemost. 1998; 80(6):894-8. View

10.

Lundbech M, Krag A, Iversen L, Brandsborg B, Madsen N, Hvas A . Elevated Thrombin Generation and Venous Thromboembolism Incidence in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Compared with Minimally Invasive Rectal Surgery. Thromb Haemost. 2024; . DOI: 10.1055/a-2413-4989. View

11.

Moik F, Ay C, Pabinger I . Risk prediction for cancer-associated thrombosis in ambulatory patients with cancer: past, present and future. Thromb Res. 2020; 191 Suppl 1:S3-S11. DOI: 10.1016/S0049-3848(20)30389-3. View

12.

Ninivaggi M, de Laat-Kremers R, Tripodi A, Wahl D, Zuily S, Dargaud Y . Recommendations for the measurement of thrombin generation: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies. J Thromb Haemost. 2021; 19(5):1372-1378. DOI: 10.1111/jth.15287. View

13.

Iversen L, Thorlacius-Ussing O . Relationship of coagulation test abnormalities to tumour burden and postoperative DVT in resected colorectal cancer. Thromb Haemost. 2002; 87(3):402-8. View

14.

Khorana A, Francis C, Culakova E, Kuderer N, Lyman G . Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2007; 5(3):632-4. DOI: 10.1111/j.1538-7836.2007.02374.x. View

15.

Larsen J, Hvas A . Fibrin Clot Formation and Lysis in Plasma. Methods Protoc. 2020; 3(4). PMC: 7712220. DOI: 10.3390/mps3040067. View

16.

Ades S, Pulluri B, Holmes C, Lal I, Kumar S, Littenberg B . Risk factors for venous thromboembolism in metastatic colorectal cancer with contemporary treatment: A SEER-Medicare analysis. Cancer Med. 2022; 11(8):1817-1826. PMC: 9041082. DOI: 10.1002/cam4.4581. View

17.

Gyldenholm T, Hvas A, Christensen T, Larsen J . Thrombin Generation Markers as Predictors of Cancer-Associated Venous Thromboembolism: A Systematic Review. Semin Thromb Hemost. 2023; 50(3):384-401. DOI: 10.1055/s-0043-1775856. View

18.

Falanga A, Marchetti M, Russo L . The mechanisms of cancer-associated thrombosis. Thromb Res. 2015; 135 Suppl 1:S8-S11. DOI: 10.1016/S0049-3848(15)50432-5. View

19.

Ay C, Dunkler D, Simanek R, Thaler J, Koder S, Marosi C . Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol. 2011; 29(15):2099-103. DOI: 10.1200/JCO.2010.32.8294. View

20.

Narasimhan V, Tan S, Kong J, Pham T, Michael M, Ramsay R . Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis. Colorectal Dis. 2020; 22(11):1482-1495. DOI: 10.1111/codi.15003. View